Monica Seles reveals battle with chronic neuromuscular disease
'I would be playing with some kids or family members, and I would miss a ball. I was like, 'Yeah, I see two balls.' These are obviously symptoms that you can't ignore,' Seles said. 'And, for me, this is when this journey started. And it took me quite some time to really absorb it, speak openly about it, because it's a difficult one. It affects my day-to-day life quite a lot.'
The 51-year-old Seles, who won her first major trophy at age 16 at the 1990 French Open and played her last match in 2003, said she was diagnosed with myasthenia gravis three years ago and is speaking publicly about it for the first time ahead of the US Open, which starts on 24 August, to raise awareness about what is known as MG.
The National Institute of Neurological Disorders and Stroke calls it 'a chronic neuromuscular disease that causes weakness in the voluntary muscles' and 'most commonly impacts young adult women (under 40) and older men (over 60) but ... can occur at any age, including childhood.'
Seles said she'd never heard of the condition until seeing a doctor and being referred to a neurologist after noticing symptoms such as double vision and weakness in her arms — 'just blowing my hair out ... became very difficult,' she said — and legs.
'When I got diagnosed, I was like, 'What?!'' said Seles, who is partnering with argenx, an immunology company headquartered in the Netherlands, to promote their Go for Greater campaign. 'So this is where — I can't emphasize enough — I wish I had somebody like me speak up about it.'
It's been three decades since Seles returned to competition at the 1995 US Open, making it to the final, more than two years after she was attacked by a man with a knife at a tournament in Hamburg, Germany.
'The way they welcomed me ... after my stabbing, I will never forget,' Seles said about the fans in New York. 'Those are the moments that stay with you.'
She talks about learning to live a 'new normal' nowadays and characterized her health as another in a series of life steps that required adapting.
'I had to, in tennis terms, I guess, reset — hard reset — a few times. I call my first hard reset when I came to the US as a young 13-year-old (from Yugoslavia). Didn't speak the language; left my family. It's a very tough time. Then, obviously, becoming a great player, it's a reset, too, because the fame, money, the attention, changes (everything), and it's hard as a 16-year-old to deal with all that. Then obviously my stabbing — I had to do a huge reset," Seles said.
'And then, really, being diagnosed with myasthenia gravis: another reset. But one thing, as I tell kids that I mentor: 'You've got to always adjust. That ball is bouncing, and you've just got to adjust,'' she added. "And that's what I'm doing now.'
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
The Independent
2 hours ago
- The Independent
Researchers discover the immune system's ‘fountain of youth' - but it has a cost
Researchers have discovered the 'fountain of youth' for cells - but it comes with a big cost. Some people over 60 years old were found to have immune systems that appear to much younger in wear-and-tear, Mayo Clinic researchers announced Thursday. The immune system is what protects us from getting sick and promotes healing. With age, the immune system's ability to protect the body from infection and disease can wane. Young immune systems are constantly exposed to new bacteria and viruses, and previous research has shown that infant immune systems beat those of adults at fighting off the invaders. Researchers now say some have immune systems that don't match their age. "We observed that these patients have very young immune systems despite being in their 60s and 70s,' Dr. Cornelia Weyand, a Mayo Clinic rheumatologist and clinician-scientist, said in a statement. 'But the price they pay for that is autoimmunity.' Autoimmunity is what happens when the immune system mistakenly attacks healthy tissues and organs. There are more than 100 known autoimmune diseases, according to the Cleveland Clinic, including lupus, multiple sclerosis, psoriasis, celiac disease and Hashimoto's thyroiditis. Women are at a higher risk than men, thanks to genetic and hormonal differences, according to Stanford Medicine. Doctors discovered this anomaly in more than 100 older patients who went to the Minnesota clinic to receive treatment for a rare autoimmune disease known as giant cell arteritis. Giant cell arteritis is an inflammation of the lining of your arteries that can affect the arteries in your head, the clinic explained. Untreated, it can lead to blindness, an aortic aneurysm, and, less commonly, stroke. It frequently causes headaches, jaw pain and vision problems. What causes the disorder remains unknown. Studying the diseased tissue of these patients, the researchers found they had specialized cells in their immune system known as 'stem-like T cells.' The cells behave like young stem cells, which are critical for repairing and maintaining a healthy immune system. But, in this case, they were spreading the autoimmune disease. Going forward, the scientists hope to learn more about this link and what they observed from the patients. "Contrary to what one may think, there are benefits to having an immune system that ages in tandem with the body," Dr. Jörg Goronzy, a Mayo Clinic researcher on aging, said. "We need to consider the price to pay for immune youthfulness. That price can be autoimmune disease."
The Sun
4 hours ago
- The Sun
Future humans ‘will be hairless & lose FOUR other body parts' thanks to modern lifestyles
SCIENTISTS warn that future humans may go hairless and even lose four other body parts due to the way we live today. Experts say that changes in diet, technology, and environment could drive these drastic evolutionary shifts over thousands of years. 7 7 Traits that were once essential for survival, like body hair or certain organs, may become redundant, gradually disappearing from the human body. Researchers are particularly focused on how modern comforts, reduced physical activity, and medical advances could reshape our anatomy in ways previously only seen in evolutionary theory. Yes — the human body is an incredible machine, vital for life, but some features that were once essential now serve little to no purpose. Here are five body parts that are slowly disappearing. Hair Body hair once served vital functions like warmth and protection. But today, it's often removed for aesthetic reasons. Apart from eyelashes and eyebrows, hair removal has become a standard grooming practice, especially among women. A study found that over 90% of women in the UK typically remove their armpit and leg hair, with many also removing substantial portions of their pubic hair. This trend is largely driven by societal norms and beauty standards. As a result, hair has become a lot finer and sparser. Breakthrough as robots with self-healing skin are step closer as boffins could bind engineered tissue to the machines Now largely cosmetic and slowly fading, scientists predict that humans may continue to lose body hair. Modern clothing, heated homes, and technological comforts also mean natural insulation is no longer vital. So, body hair may become even more finer, sparser or even disappear entirely. Wisdom teeth 7 Wisdom teeth, or third molars, originally helped our ancestors grind down tough, raw foods like roots, nuts, and uncooked meat. But modern cooking and softer diets mean most of us no longer need them. In the UK, studies show that around 20% of adults have had at least one wisdom tooth removed, while diets rich in processed and cooked foods have made these extra molars largely redundant. About 1 in 5 people never develop all four wisdom teeth, showing how they are already becoming less common. Our jaws have shrunk over generations, and with softer modern diets, these third molars often cause crowding or pain. Dental problems caused by these teeth — such as overcrowding, infections, or impaction — are a major reason for removal, with the NHS performing tens of thousands of extractions every year. This could mean future generations may lose wisdom teeth altogether, as evolution adapts to our easier-to-chew meals. Over time, evolution may render wisdom teeth completely unnecessary, meaning future humans could be born without them entirely. Tailbone (coccyx) 7 The tailbone, or coccyx, is a leftover from our primate tails and originally helped with balance and supporting a tail. Today, it serves little purpose, though it still supports some pelvic muscles. Modern lifestyles — with flat surfaces, chairs, and less need for climbing or gripping — mean the coccyx is largely redundant. Coccyx injuries are fairly common in the UK, with around 1 in 50 people experiencing tailbone pain at some point, highlighting its vulnerability despite its reduced evolutionary role. Coccyx pain (coccydynia) affects about 2% of the UK population, often from falls, prolonged sitting, or childbirth. Tailbone fractures are relatively rare but account for around 1–5% of all fractures of the spine. As its original role for balance is no longer needed, the coccyx is used more as a historical marker. Over the years, natural selection could favour smaller or even absent tailbones. Some evolutionary studies suggest the coccyx has shrunk in humans compared with our primate relatives. Scientists suggest it may gradually shrink or disappear in future humans. Appendix Historically, our ancestors relied on the appendix to digest cellulose-rich plants. The appendix may have been a handy tool for digesting tough, fibrous material, but today, it's mostly redundant. Modern cooked and processed diets mean we no longer need this little organ to break down food. However, some research suggests it may play a minor role in immune function, housing beneficial gut bacteria. Despite its reduced purpose, appendicitis still affects around 7,000 people in the UK each year, making the appendix one of the most commonly removed organs. That's about 1 in 20 people who will experience appendicitis at some point in their lives. Essentially, it's a vestige of our evolutionary past — useful for our ancestors, but largely obsolete for humans living in the modern world. The appendix is usually around 8–10cm long, but can vary in size. Over thousands of years, natural selection may favour individuals with smaller or absent appendices, gradually phasing it out of the human body — leaving it as just another vestigial remnant of our evolutionary past. As humans continue to eat softer, cooked, and processed foods, the organ's original role in digesting tough plant fibers becomes unnecessary. In the future, scientists predict the appendix could disappear entirely. Ear muscles 7 Ear muscles were once used to swivel our ears toward sounds, just like cats and dogs do. Our ancestors likely used these ear muscles to pivot their ears toward sounds, helping them detect predators, prey, or other dangers in their environment. In a world without modern technology or protective housing, being able to quickly pick up noises from different directions would have been a useful survival tool — something we no longer need today. Today, most people's ear muscles are inactive, serving little to no practical purpose. For the rare few who can still twitch them, it's more of a quirky party trick than a survival skill. Studies suggest that only around 10–20% of people can voluntarily move their ears, with the ability being more common in men than women. This tiny fraction highlights just how redundant these muscles have become, reduced to little more than a novelty rather than a functional tool for detecting sounds. Scientists predict that, over thousands of years, these ear muscles may shrink or disappear entirely. As humans rely more on technology — like headphones, alarms, and visual cues — rather than acute hearing for survival, natural selection may phase out this once-useful feature, leaving future generations with fully immobile ears. A timeline of life on Earth Here's a brief history of life on our planet 4.6billion years ago – the origin of Earth 3.8billion years ago – first life appears on Earth 2.1billion years ago – lifeforms made up of multiple cells evolve 1.5billion years ago – eukaryotes, which are cells that contain a nucleus inside of their membranes, emerge 550million years ago – first arthropods evolve 530million years ago – first fish appear 470million years ago – first land plants appear 380million years ago – forests emerge on Earth 370million years ago – first amphibians emerge from the water onto land 320million years ago – earliest reptiles evolve 230million years ago – dinosaurs evolve 200million years ago – mammals appear 150million years ago – earliest birds evolve 130million years ago – first flowering plants 100million years ago – earliest bees 55million years ago – hares and rabbits appear 30million years ago – first cats evolve 20million years ago – great apes evolve 7million years ago –first human ancestors appear 2million years ago – Homo erectus appears 300,000 years ago – Homo sapiens evolves 50,000 years ago – Eurasia and Oceania colonised 40,000 years ago – Neandethal extinction
Medical News Today
5 hours ago
- Medical News Today
Could a new vaccine help prevent colorectal, pancreatic cancer recurrence?
Gastrointestinal cancers — including pancreatic, and colorectal cancers — account for about 26% of all cancers worldwide. Both pancreatic and colorectal cancers are susceptible to gene mutations called KRAS mutations, which can make these cancers harder to treat.A new study shows that an 'off-the-shelf' vaccine may help prevent or delay cancer recurrence in people with colorectal or pancreatic cancer tumors driven by KRAS mutations. Research shows that gastrointestinal cancers — including stomach, liver, esophageal, pancreatic, and colorectal cancers — account for about 26% of all cancers worldwide and 35% of all cancer-related deaths. Colorectal cancer is currently considered to be the third most common type of cancer globally, and the second most common cause of cancer-related death. While pancreatic cancer ranks as the 12th most common cancer worldwide, it is the sixth leading cause of cancer-related death. Both pancreatic and colorectal cancers are susceptible to gene mutations called KRAS mutations. These mutations can cause cells to grow and divide very rapidly, potentially leading to cancer. Cancers with KRAS mutations have historically been hard to treat. Now, a new study published in the journal Nature Medicine shows that an 'off-the-shelf' vaccine may help prevent or delay cancer recurrence in people with colorectal or pancreatic cancer tumors driven by KRAS mutations. What does the 'off-the-shelf' cancer vaccine do?For this study, which included follow-up data from the AMPLIFY-201 phase 1 trial, researchers recruited 25 participants with either colon or pancreatic cancer, who had undergone surgery and still showed traces of cancer DNA in their blood, which is an indicator of potential cancer received injections of ELI-002 2P — an 'off-the-shelf' or standardized vaccine that can revive the body's immune system so it recognizes and attacks cancer cells in a general way. 'We took a unique approach in AMPLIFLY-201, employing a diagnostic that detects circulating tumor DNA (ctDNA) and tests that identify a tumor protein, CA19-9, in the blood, to identify patients who show signs of minimal residual disease in their blood, but before relapse is detected in traditional radiographic scans,' Zev Wainberg, MD, MSc, professor of medicine at the David Geffen School of Medicine at UCLA and researcher in the UCLA Health Jonsson Comprehensive Cancer Center, and first author of this study, explained for Medical News Today.'This group of pancreatic patients in historical studies really needed better treatment since their median time until relapse was historically only five to six months. The study also enrolled five colorectal cancer patients, who also had high risk of relapse with positive tests to tumor markers in the blood,' Wainberg told survival longer than previous results indicatedAt the study's conclusion, researchers found that after a follow-up of almost 20 months, participants' average relapse-free survival was 16.33 months and average overall survival was almost 29 months. 'These are a lot longer than the historical results of these patients,' Wainberg reported that 24% of participants experienced a complete clearing of biomarkers associated with their tumors. And 67% of participants developed immune responses to other tumor-related mutations. 'Targeting KRAS has long been considered one of the difficult challenges in cancer therapy,' Wainberg said in a press release, noting that:'This study shows that the ELI-002 2P vaccine can safely and effectively train the immune system to recognize and fight cancer-driving mutations. It offers a promising approach to generating precise and durable immune responses without the complexity or cost of fully personalized vaccines.'Could this experimental vaccine possibly prevent cancer? Anton Bilchik, MD, PhD, surgical oncologist, chief of medicine and Director of the Gastrointestinal and Hepatobiliary Program at Providence Saint John's Cancer Institute in Santa Monica, CA, told MNT that these findings are very exciting and very important, given that pancreatic cancer is a deadly cancer and the treatments, while being more effective than they were maybe 10 years ago, are still relatively ineffective in terms of curing patients with pancreatic cancer. 'Secondly, immunotherapy has really not been shown to be effective for either the treatment of pancreas cancer, and has been shown to be effective only in a very small subset of patients with advanced colon cancer,' Bilchik, who was not involved in the study, added.'So the fact that this study shows that a T cell-based vaccine can improve survival in patients with pancreas cancer and colon cancer is innovative, is very exciting, and certainly opens up the possibilities of immunotherapy as a possible effective treatment for what is a deadly cancer, in particular, pancreas cancer,' he this study is important, Bilchik said it is just the tip of the iceberg, with more studies needed to be done, including some looking at whether or not this vaccine might be able to help prevent cancer in the first place. 'So before people have a chance to get pancreas cancer, if they get a blood test that shows tumor cells or shows that they're at risk for getting these cancers, would this type of vaccine prevent them from getting cancer?' he asked. Why novel approaches to KRAS-driven cancers are importantMNT also spoke with Usman Shah, MD, medical director of gastrointestinal oncology at Atlantic Health's Overlook Medical Center in Summit, New Jersey, about this who was not involved in the research, commented he reviewed the findings with both enthusiasm and cautious optimism.'In this trial, patients with minimal residual disease — as evidenced by biomarkers like CA19-9, CEA, and/or circulating tumor DNA — were treated with ELI‑002, a cancer vaccine targeting KRAS mutations,' Shah said.'This phase 1 study demonstrated that 68% of participants developed robust T cell responses, which importantly correlated with significantly improved relapse-free survival and overall survival. As this approach uses an off-the-shelf vaccine approach, it can be more accessible to more patients in a shorter time than personalized vaccine treatments.' – Usman Shah, MD'The importance of developing novel approaches for KRAS-driven cancers cannot be overstated, as KRAS mutations are prevalent in several solid tumors and are associated with poor prognosis,' he continued. 'For example, 90-95% of pancreatic cancers harbor a KRAS mutation. ELI‑002's ability to induce strong and durable immune responses offers a potential strategy to prevent cancer recurrence in high-risk patients.' 'Early hints from the randomized AMPLIFY‑7P trial evaluating this approach against standard of care are encouraging, although final results are pending,' Shah added. 'Continued investment in such innovative approaches is essential to improving outcomes for patients with KRAS-mutant cancers.'
